Afuco™ Anti-HBV ADCC Therapeutic Antibody (Exbivirumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to HBV. Exbivirumab is a human monoclonal antibody developed for the treatment of hepatitis B infections.
Supplier Creative Biolabs
Product # AFC-TAB-746
Pricing Inquiry
Host Human
Target HBV
Species Reactivity HBV
Type ADCC enhanced antibody
Applications FC, IP, ELISA, Neut, FuncS, IF
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback